Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ACUTA CAPITAL PARTNERS, LLC (CIK 1582844) reported $141.8M across 24 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: PRAX ($27.4M, 19.30%), TERN ($26.1M, 18.44%), WHWK ($11.8M, 8.30%), TNGX ($9.2M, 6.52%), DRUG ($8.2M, 5.76%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | $27.4M | 19.30% | 84,901 | Added |
| 2 | TERN | TERNS PHARMACEUTICALS INC | $26.1M | 18.44% | 495,772 | Trimmed |
| 3 | WHWK | WHITEHAWK THERAPEUTICS INC | $11.8M | 8.30% | 3.4M | Hold |
| 4 | TNGX | TANGO THERAPEUTICS INC | $9.2M | 6.52% | 441,831 | Added |
| 5 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $8.2M | 5.76% | 111,996 | Added |
| 6 | STRO | SUTRO BIOPHARMA INC | $6.7M | 4.73% | 269,425 | Added |
| 7 | ERAS | ERASCA INC | $5.7M | 4.05% | 354,575 | New |
| 8 | SRZN | SURROZEN INC | $5.0M | 3.55% | 172,847 | Trimmed |
| 9 | OCUL | OCULAR THERAPEUTIX INC | $5.0M | 3.54% | 592,108 | Trimmed |
| 10 | CMPX | COMPASS THERAPEUTICS INC | $4.5M | 3.17% | 849,076 | Trimmed |
| 11 | NERV | MINERVA NEUROSCIENCES | $4.3M | 3.02% | 709,500 | Hold |
| 12 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.6M | 2.52% | 191,760 | Added |
| 13 | ARGX | ARGEN SE - ADR | $3.4M | 2.42% | 4,690 | Trimmed |
| 14 | IDYA | IDEAYA BIOSCIENCES INC | $2.8M | 1.96% | 48,584 | New |
| 15 | OCS | OCULIS HOLDING AG | $2.6M | 1.84% | 98,339 | Trimmed |
| 16 | RVMD | REVOLUTION MEDICINES INC | $2.5M | 1.79% | 26,069 | Added |
| 17 | FDMT | 4D MOLECULAR THERAPEUTICS INC | $2.3M | 1.59% | 242,255 | New |
| 18 | AMLX | AMYLYX PHARMACEUTICALS INC | $2.1M | 1.48% | 151,067 | Trimmed |
| 19 | TSHA | TAYSHA GENE THERAPIES INC | $2.0M | 1.39% | 439,464 | Trimmed |
| 20 | DSGN | DESIGN THERAPEUTICS INC | $1.6M | 1.10% | 145,900 | Trimmed |
| 21 | UTHR | UNITED THERAPEUTICS CORP | $1.3M | 0.93% | 2,224 | Trimmed |
| 22 | TRDA | ENTRADA THERAPEUTICS INC | $1.1M | 0.80% | 89,358 | New |
| 23 | AVTX | AVALO THERAPEUTICS INC | $907,863 | 0.64% | 60,808 | New |
| 24 | LB PHARMACEUTICALS INC | $713,143 | 0.50% | 28,919 | Trimmed | |
| 25 | MAZE | MAZE THERAPEUTICS INC | $577,150 | 0.41% | 19,335 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31